Meropenem Steriscience (Meropenem)

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious infections caused by susceptible bacteria.

• Complicated intra‑abdominal infection: provides coverage against mixed aerobic and anaerobic pathogens.
• Hospital‑acquired pneumonia including ventilator‑associated pneumonia: targets resistant Gram‑negative organisms.
• Complicated urinary tract infection: eradicates multidrug‑resistant Enterobacteriaceae.
• Bacterial meningitis: achieves therapeutic concentrations in cerebrospinal fluid.
• Sepsis and bloodstream infections: offers rapid bactericidal activity against a wide range of pathogens.

• Meropenem inhibits bacterial cell wall synthesis by binding with high affinity to penicillin‑binding proteins (PBPs). This binding disrupts the final transpeptidation step of peptidoglycan cross‑linking, weakening the cell wall and leading to osmotic lysis and bacterial cell death. Its broad spectrum includes most Gram‑negative, Gram‑positive and anaerobic organisms, and it is resistant to most β‑lactamases.

Adverse reactions may occur with meropenem therapy and should be monitored.

Common Side Effects

• Nausea: mild to moderate gastrointestinal discomfort.
• Diarrhea: may be watery and self‑limiting.
• Headache: transient and usually resolves without intervention.
• Rash: erythematous skin eruption without systemic involvement.
• Elevated liver enzymes: transient increase in ALT/AST levels.
• Injection site pain: local discomfort at the infusion site.

Serious or Rare Side Effects

• Seizures: especially in patients with renal impairment or CNS disorders.
• Clostridioides difficile‑associated colitis: severe diarrhea requiring medical attention.
• Anaphylaxis: acute hypersensitivity reaction with respiratory and cardiovascular compromise.
• Severe neutropenia: marked reduction in white blood cell count.

Meropenem should be used with caution in specific clinical situations.

• Renal impairment: adjust dose according to creatinine clearance.
• Hypersensitivity: discontinue immediately if allergic reaction occurs.
• Seizure risk: monitor patients with a history of epilepsy or CNS disease.
• Pregnancy: use only when the potential benefit justifies the potential risk to the fetus.
• Drug interactions: review concomitant medications for possible interactions.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines, requiring careful management.

Major Interactions (Avoid)

• Valproic acid: carbapenems reduce serum valproate levels, risking seizure breakthrough.
• Probenecid: may increase meropenem plasma concentrations, heightening toxicity risk.
• Aminoglycosides: concurrent use can augment nephrotoxicity.

Moderate Interactions (Monitor Closely)

• Loop diuretics: monitor renal function and electrolytes.
• Anticoagulants (e.g., warfarin): observe INR for potential alterations.